Project Details
| Short title | CS2009-101 |
|---|---|
| Status | Finished |
| Effective start/end date | 11/03/25 → 6/02/26 |
CTU: A Phase I, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of CS2009, a tri-specific antibody targeting PD-1/VEGFA/CTLA-4, in Participants with Advanced Solid Tumors
- Park, John (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Chik, Jenny (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
- Gajkowska, Anna (Clinical Trial Unit Staff)
Project: Research